Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-280-7 | CAS number: 56602-77-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Physicochemical properties
The substance bicyclo[2.2.1]heptanebis(methylamine) (NBDA) is a clear liquid. The molecular weight (MW) is 154 g/mol and its water solubility is >1000 g/L (water-soluble) with a measured log Pow value of 1.0 at 25 °C. The vapour pressure was determined to be 16 Pa at 20 °C and 21 Pa at 25 °C.
Absorption
Oral absorption
The low molecular weight in combination with the high water-solubility and low octanol/water partition coefficient indicate that NBDA can be highly absorbed from the gut.
Repeated dose (subacute) oral, acute oral and reproduction/developmental toxicity (OECD 421) studies available for NBDA reported no reproductive/developmental effects. There were, however, toxicity effects starting from the dose of 15 mg/kg bw/day. Target organs were the liver and adrenal gland. These data in combination with the high water solubility of NBDA, indicate that the substance is absorbed by the GI tract.
Therefore, in the absence of any quantitative data, the default value of 100% is assumed for oral absorption in accordance with the ECHA guidance.
Dermal absorption
A substance must be sufficiently soluble in water to partition from the stratum corneum into the epidermis, and since the water solubility of NBDA is high enough, it is expected that dermal penetration will also be extensive. This is further supported by the estimated Log Pow values, which also suggest that NBDA is dermally absorbed.
In conclusion, the above data in combination with the fact that NBDA is considered to be a skin corrosive, the default value of 100% is assumed for dermal absorption.
Inhalation absorption
With respect to inhalation absorption, in the absence of any quantitative data and as a worst-case assumption for human health risk assessment purposes absorption by inhalation of NBDA is assumed to be 100%.
Distribution
The repeat-dose oral toxicity study reported several toxicity effects and the identified target organs were the liver and the adrenal gland. Moreover, the low molecular weight and low Log Pow value suggest water solubility. No evidence of bioaccumulation was reported from the available repeat-dose toxicity studies, despite the substance was found to not be readily biodegradable. On this basis, potential for bioaccumulation is considered low.
Metabolism and Elimination
Nothing could be inferred from the results of the Ames test or in vitro genotoxicity studies (chromosome aberration and gene mutations in mammalian cells), because NBDA was not genotoxic, mutagenic or clastogenic in either the presence or absence of S9 metabolising system. The absence of toxicity effects in pups from the OECD 421, indicates that NBDA is not excreted in milk. The nature of the substance (hydrophilicity and water solubility) suggest that both the parent compound and any metabolite will probably be excreted in urine.
Conclusion
Based on in vitro and in vivo data from studies performed with NBDA, oral, dermal and inhalation absorption are assumed to be 100%. Furthermore, the potential for bioaccumulation is low, and the substance is expected to be completely excreted in urine.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 100
- Absorption rate - inhalation (%):
- 100
Additional information
The substance has been studied in in vivo toxicity and physico-chemical studies. These results in combination with the results from in vitro and in vivo studies were used to determine a toxicokinetic profile of the substance.
Based on in vitro and in vivo data on the substance oral, dermal and inhalation absorption are assumed to be 100%. Furthermore, the potential for bioaccumulation is low, and the substance is expected to be completely excreted in urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.